Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Operating Income (2018 - 2026)

AdaptHealth has reported Operating Income over the past 8 years, most recently at -$73.3 million for Q4 2025.

  • For Q4 2025, Operating Income fell 175.03% year-over-year to -$73.3 million; the TTM value through Dec 2025 reached $90.9 million, down 65.54%, while the annual FY2025 figure was $90.9 million, 65.54% down from the prior year.
  • Operating Income for Q4 2025 was -$73.3 million at AdaptHealth, down from $61.7 million in the prior quarter.
  • Over five years, Operating Income peaked at $97.7 million in Q4 2024 and troughed at -$461.0 million in Q3 2023.
  • A 5-year average of $8.6 million and a median of $52.5 million in 2022 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: surged 471.01% in 2021 and later plummeted 970.72% in 2023.
  • Year by year, Operating Income stood at $69.1 million in 2021, then plummeted by 61.3% to $26.7 million in 2022, then crashed by 914.77% to -$217.8 million in 2023, then surged by 144.84% to $97.7 million in 2024, then plummeted by 175.03% to -$73.3 million in 2025.
  • Business Quant data shows Operating Income for AHCO at -$73.3 million in Q4 2025, $61.7 million in Q3 2025, and $79.3 million in Q2 2025.